ClinDet-Bench: Beyond Abstention, Evaluating Judgment Determinability of LLMs in Clinical Decision-Making
Organizations: Kyoto University, Department of Biomedical Data Intelligence · Kyoto University, Department of Cardiovascular Medicine · The University of Tokyo
Abstract
Clinical decisions are often required under incomplete information. Clinical experts must identify whether available information is sufficient for judgment, as both premature conclusion and unnecessary abstention can compromise patient safety. To evaluate this capability of large language models (LLMs), we developed ClinDet-Bench, a benchmark based on clinical scoring systems that decomposes incomplete-information scenarios into determinable and undeterminable conditions. Identifying determinability requires considering all hypotheses about missing information, including unlikely ones, and verifying whether the conclusion holds across them. We find that recent LLMs fail to identify determinability under incomplete information, producing both premature judgments and excessive abstention, despite correctly explaining the underlying scoring knowledge and performing well under complete information. These findings suggest that existing benchmarks are insufficient to evaluate the safety of LLMs in clinical settings. ClinDet-Bench provides a framework for evaluating determinability recognition, leading to appropriate abstention, with potential applicability to medicine and other high-stakes domains, and is publicly available.
Figures & tables
| Component | Points | |
|---|---|---|
| C | Congestive heart failure | 1 |
| H | Hypertension | 1 |
| A | Age years | 1 |
| D | Diabetes mellitus | 1 |
| S 2 | Prior stroke or transient ischemic attack | 2 |
| Model | Accuracy |
|---|---|
| GPT-5.2 | 0.88 |
| o3-pro | 1.00 |
| GPT-4o | 0.94 |
| Gemini 3 Pro | 0.94 |
| Claude Opus 4.5 | 0.94 |
| Llama 4 Maverick | 0.69 |
| Base | CoT | Safe | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Model | Complete | Incomplete- Determinable | Incomplete- Undeterminable | Complete | Incomplete- Determinable | Incomplete- Undeterminable | Complete | Incomplete- Determinable | Incomplete- Undeterminable |
| GPT-5.2 | 0.93 | 0.85 | 0.11 ∗ | 0.96 | 0.81 | 0.57 ∗ | 0.96 | 0.85 | 0.57 ∗ |
| o3-pro | 1.00 | 0.97 | 0.34 ∗ | 1.00 | 0.97 | 0.38 ∗ | 1.00 | 0.97 | 0.47 ∗ |
| GPT-4o | 1.00 | 0.82 ∗ | 0.57 ∗ | 1.00 | 0.79 ∗ | 0.60 ∗ | 1.00 | 0.86 ∗ | 0.70 ∗ |
| Gemini 3 Pro | 1.00 | 1.00 | 0.43 ∗ | 1.00 | 1.00 | 0.50 ∗ | 1.00 | 1.00 | 0.67 ∗ |
| Claude Opus 4.5 | 0.97 | 0.93 | 0.57 ∗ | 1.00 | 1.00 | 0.60 ∗ | 1.00 | 0.93 | 0.77 ∗ |
| Error Type | Count | % |
|---|---|---|
| Imputation of missing information | 102 | 81.6 |
| Judgment based on incompleteness | 18 | 14.4 |
| Others | 5 | 4.0 |
| Total | 125 | 100.0 |
Appendix figures & tables10 assets
Supplementary material from the paper’s appendix.
Appendix
| Scoring System | Target Condition | Reference |
|---|---|---|
| A-DROP Score | Community-acquired pneumonia | ( Miyashita et al., 2006 ; Mukae et al., 2025 ) |
| Alvarado Score | Acute appendicitis | ( Alvarado, 1986 ; Di Saverio et al., 2020 ) |
| Apgar Score | Newborn assessment | ( Apgar, 1953 ; noa, 2015 ) |
| BISAP Score | Acute pancreatitis | ( Wu et al., 2008 ; Tenner et al., 2013 ) |
| Bishop Score | Labor induction | ( Bishop, 1964 ; noa, 2009 ) |
| Blatchford Score | Upper gastrointestinal bleeding | ( Blatchford et al., 2000 ; Laine et al., 2021 ) |
| Model | Provider | Model ID |
|---|---|---|
| GPT-5.2 | OpenAI | gpt-5.2-2025-12-11 |
| o3-pro | OpenAI | o3-pro-2025-06-10 |
| GPT-4o | OpenAI | gpt-4o-2024-11-20 |
| Gemini 3 Pro | gemini-3-pro-preview | |
| Claude Opus 4.5 | Anthropic | claude-opus-4-5-20251101 |
| Llama 4 Maverick | Meta | llama-4-maverick |
| Scenario Type | Ground Truth Label | |||
|---|---|---|---|---|
| Met | Not met | Unable to determine | All | |
| Complete | 16 | 16 | 0 | 32 |
| Incomplete- Determinable | 14 | 16 | 0 | 30 |
| Incomplete- Undeterminable | 0 | 0 | 32 | 32 |
| All | 30 | 32 | 32 | 94 |
| Model | Complete | Incomplete- Determinable | Incomplete- Undeterminable |
|---|---|---|---|
| GPT-5.2 | 28 | 26 | 28 |
| o3-pro | 32 | 30 | 32 |
| GPT-4o | 30 | 28 | 30 |
| Gemini 3 Pro | 30 | 29 | 30 |
| Claude Opus 4.5 | 30 | 28 | 30 |
| Llama 4 Maverick | 22 | 21 | 22 |
| Base | CoT | Safe | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Model | Complete | Incomplete- Determinable | Incomplete- Undeterminable | Complete | Incomplete- Determinable | Incomplete- Undeterminable | Complete | Incomplete- Determinable | Incomplete- Undeterminable |
| GPT-5.2 | 0.96 (27/28) | 0.88 (23/26) | 0.64 (18/28) ∗ | 0.96 (27/28) | 0.81 (21/26) | 0.79 (22/28) | 1.00 (28/28) | 0.88 (23/26) | 0.64 (18/28) ∗ |
| o3-pro | 1.00 (32/32) | 0.97 (29/30) | 1.00 (32/32) | 1.00 (32/32) | 1.00 (30/30) | 0.88 (28/32) | 1.00 (32/32) | 1.00 (30/30) | 0.81 (26/32) ∗ |
| GPT-4o | 1.00 (30/30) | 1.00 (28/28) | 1.00 (30/30) | 1.00 (30/30) | 0.96 (27/28) | 0.97 (29/30) | 1.00 (30/30) | 0.96 (27/28) | 0.93 (28/30) |
| Gemini 3 Pro | 1.00 (30/30) | 1.00 (29/29) | 0.97 (29/30) | 1.00 (30/30) | 1.00 (29/29) | 0.97 (29/30) | 1.00 (30/30) | 0.97 (28/29) | 1.00 (30/30) |
| Claude Opus 4.5 | 0.97 (29/30) | 0.93 (26/28) | 0.77 (23/30) | 1.00 (30/30) | 0.96 (27/28) | 0.67 (20/30) ∗ | 0.90 (27/30) | 0.86 (24/28) | 0.63 (19/30) ∗ |
| Base | CoT | Safe | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Model | Complete | Incomplete- Determinable | Incomplete- Undeterminable | Complete | Incomplete- Determinable | Incomplete- Undeterminable | Complete | Incomplete- Determinable | Incomplete- Undeterminable |
| GPT-5.2 | 0.93 (25/27) | 0.83 (19/23) | 0.11 (2/18) ∗ | 0.96 (26/27) | 0.90 (19/21) | 0.55 (12/22) ∗ | 0.96 (27/28) | 0.91 (21/23) | 0.44 (8/18) ∗ |
| o3-pro | 1.00 (32/32) | 0.97 (28/29) | 0.34 (11/32) ∗ | 1.00 (32/32) | 0.97 (29/30) | 0.29 (8/28) ∗ | 1.00 (32/32) | 0.97 (29/30) | 0.35 (9/26) ∗ |
| GPT-4o | 1.00 (30/30) | 0.82 (23/28) ∗ | 0.57 (17/30) ∗ | 1.00 (30/30) | 0.78 (21/27) ∗ | 0.59 (17/29) ∗ | 1.00 (30/30) | 0.89 (24/27) | 0.68 (19/28) ∗ |
| Gemini 3 Pro | 1.00 (30/30) | 1.00 (29/29) | 0.45 (13/29) ∗ | 1.00 (30/30) | 1.00 (29/29) | 0.48 (14/29) ∗ | 1.00 (30/30) | 1.00 (28/28) | 0.67 (20/30) ∗ |
| Claude Opus 4.5 | 1.00 (29/29) | 0.96 (25/26) | 0.48 (11/23) ∗ | 1.00 (30/30) | 1.00 (27/27) | 0.40 (8/20) ∗ | 1.00 (27/27) | 0.96 (23/24) | 0.68 (13/19) ∗ |
| Base | CoT | Safe | |
|---|---|---|---|
| Imputation of missing information | 77 | 102 | 56 |
| Judgment based on incompleteness | 16 | 18 | 25 |
| Others | 6 | 5 | 4 |
| No reasoning output | 56 | 0 | 29 |
| Total errors | 155 | 125 | 114 |
Clinical Language Model Evaluation
Clinical language model evaluation measures whether AI systems are accurate, safe, fair, and useful across medical tasks and care settings.
See all 418 papers